Author:
Usui Noriko,Matsushima Kouji,Pilaro Anne M.,Longo Dan L.,Wiltrout Robert H.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Arend WP. Interleukin 1 receptor antagonist. J Clin Invest 1991; 88: 1445–1451
2. Baranellec D, Markovits J, Chouaib S. Potentiation of TNF-mediated cell killing by VP-16: Relationship to DNA single-strand break formation. Int J Cancer 1990; 46: 1048–1053.
3. Berger NA, Chatterjee S, Schmotzer JA, Helms SR. Etoposide(VP-16-213)-induced gene alterations: Potential contribution to cell death. Proc Natl Acad Sci USA 1991; 88: 8740–8743.
4. Braunschweiger PG, Jones SA, Johnson CS, Furmanski P. Potentiation of mitomycin C and profiromycin antitumor activity in solid tumor models by recombinant human interleukin 1α. Cancer Res 1991; 51: 5454–5460
5. Burger JK, Marshall F, Isaacs JT. Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in xenograft model. J Urol 1989; 142: 160–164
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献